New cocktail shows promise against tough colon cancer

This study tested a combination of the targeted drug cetuximab with a strong chemotherapy mix (FOLFIRINOX) as a first treatment for people whose colorectal cancer had spread and could not be removed by surgery. The goal was to see how many patients had their tumors shrink or disappear. The trial included 42 adults with good performance status, regardless of whether their cancer expressed the EGFR gene. The approach aims to control the disease, not cure it, as ongoing management is expected.